De Ying Cao

Director/Board Member at HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.

65 year

Health Technology

Consumer Services

Profile

De Ying Cao is an Independent Director at Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Hebei Yipin Pharmaceutical Co., Ltd., and a Professor at Hebei Medical University.
Cao's former position was as an Independent Director at Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

De Ying Cao active positions

Companies	Position	Start
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	Director/Board Member	2021-12-29
Hebei Medical University	Corporate Officer/Principal	2011-08-07
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Director/Board Member	2021-04-30

All active positions of De Ying Cao

Former positions of De Ying Cao

Companies	Position	End
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	Director/Board Member	-

See the detail of De Ying Cao's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of De Ying Cao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	Health Technology

Private companies	1
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Health Technology